4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-25-005067
CHIEF EXECUTIVE OFFICER sold 2,159 shares at $1.15 ($2,483)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lettmann Jason CHIEF EXECUTIVE OFFICER | 2025-02-19 | Sale | −2,159 | $1.15 | $2,483 | 170,270 | D |
| Open-market sales · 2,159 sh · avg $1.15 · $2,483 | |||||||
Loading xslF345X05/form4-02212025_090215.xml…